Literature DB >> 12234312

Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study.

Ronald M A Henry1, Piet J Kostense, Griët Bos, Jacqueline M Dekker, Giel Nijpels, Robert J Heine, Lex M Bouter, Coen D A Stehouwer.   

Abstract

BACKGROUND: Cardiovascular mortality is extremely high in end-stage renal disease. Cardiovascular mortality risk also is increased in selected (high-risk) individuals with mild to moderate impairment of renal function. It is not clear whether a similar association exists in the general population and, if so, through what mechanisms. We investigated the association of renal function with all-cause and cardiovascular mortality in a population-based cohort and explored potential mechanisms underlying any such relationship.
METHODS: An age-, sex-, and glucose-tolerance-stratified sample (N = 631) of a population-based cohort aged 50 to 75 years was followed prospectively. After up to 10.2 years of follow-up, 117 subjects had died (50 of cardiovascular causes). At baseline, renal function was estimated by the serum creatinine level, the Cockcroft-Gault formula and Levey's equation.
RESULTS: At baseline, the mean age was 64 +/- 7 years, 48% were men, 55% had hypertension, and 27% (by design) had type 2 diabetes. Serum creatinine was 91.7 +/- 19.0 micromol/L; creatinine clearance as estimated by the Cockroft-Gault formula was 72.5 +/- 13.7 mL/min/1.73 m(2), and the glomerular filtration rate (GFR) estimated by Levey's equation was 67.8 +/- 12.1 mL/min/1.73 m(2). Renal function was inversely associated with all-cause and with cardiovascular mortality. Relative risks (95% confidence intervals) were 1.08 (1.04 to 1.13) and 1.11 (1.07 to 1.16) per 5 micromol/L increase of serum creatinine; 1.07 (0.98 to 1.17) and 1.15 (1.01 to 1.31) for each decrease of 5 mL/min/1.73 m(2) creatinine clearance; and 1.15 (1.05 to 1.26) and 1.26 (1.12 to 1.42) for each decrease of 5 mL/min/1.73 m(2) of GFR. These associations remained after adjusting for age, sex, glucose tolerance status, hypertension, prior cardiovascular disease, low-density lipoprotein cholesterol, homocysteine, (micro)albuminuria, von Willebrand factor, soluble vascular adhesion molecule-1 and C-reactive protein. Analyses in diabetic and hypertensive subjects gave similar results.
CONCLUSION: Mild to moderate loss of renal function is strongly associated with an increased risk of cardiovascular mortality. The mechanism behind this association is unclear but does not appear to involve common risk factors such as hypertension, diabetes or hyperhomocysteinemia. Estimation of renal function by relatively simple methods therefore may be a valuable tool for cardiovascular risk assessment over and above that provided by conventional risk factors. Our results were obtained in a general middle-aged to elderly population, and thus have broad applicability.

Entities:  

Mesh:

Year:  2002        PMID: 12234312     DOI: 10.1111/j.1523-1755.2002.kid571.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  97 in total

1.  Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus.

Authors:  R Lertnawapan; A Bian; Y H Rho; P Raggi; A Oeser; J F Solus; T Gebretsadik; A Shintani; C M Stein
Journal:  Lupus       Date:  2011-11-09       Impact factor: 2.911

2.  Minor renal dysfunction: an emerging independent cardiovascular risk factor.

Authors:  E Ritz
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

3.  Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography.

Authors:  Gholamreza Davoodi; Samira Mehrabi Pari; Mehrnaz Rezvanfard; Mahmood Sheikh Fathollahi; Manouchehr Amini; Elham Hakki; Ali Kazemisaeid; Ahmad Yaminisharif
Journal:  Int Urol Nephrol       Date:  2011-10-16       Impact factor: 2.370

4.  Predictivity of survival according to different equations for estimating renal function in community-dwelling elderly subjects.

Authors:  Francesco Pizzarelli; Fulvio Lauretani; Stefania Bandinelli; Gwen B Windham; Anna Maria Corsi; Sandra V Giannelli; Luigi Ferrucci; Jack M Guralnik
Journal:  Nephrol Dial Transplant       Date:  2008-11-06       Impact factor: 5.992

5.  A temporary loop ileostomy affects renal function.

Authors:  Bodil Gessler; Eva Haglind; Eva Angenete
Journal:  Int J Colorectal Dis       Date:  2014-07-17       Impact factor: 2.571

6.  Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Authors:  Pupalan Iyngkaran; Merlin Thomas; William Majoni; Nagesh S Anavekar; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2012-10-31       Impact factor: 2.041

7.  Cardiovascular Disease Outcomes Related to Early Stage Renal Impairment After Liver Transplantation.

Authors:  Lisa B VanWagner; Samantha Montag; Lihui Zhao; Norrina B Allen; Donald M Lloyd-Jones; Arighno Das; Anton I Skaro; Samuel Hohmann; John J Friedewald; Josh Levitsky
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

8.  Soluble TWEAK levels are independently associated with coronary artery disease severity in patients with stage 2-3 kidney disease.

Authors:  Alper Azak; Mehmet Fatih Akdoğan; Nazım Denizli; Bülent Huddam; Gülay Koçak; Murat Gücün; Mustafa Adem Tatlısu; Recep Demirci; Bilal Yılmaz; Mehmet Dikeç; Murat Bakırtaş; Ibrahim Akdağ; Murat Duranay
Journal:  Int Urol Nephrol       Date:  2013-09-17       Impact factor: 2.370

9.  Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.

Authors:  L Kristin Newby; Manjushri V Bhapkar; Harvey D White; David J Moliterno; Nancy M Allen LaPointe; David E Kandzari; Freek W A Verheugt; Judith M Kramer; Paul W Armstrong; Robert M Califf
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

10.  Metabolic abnormalities, but not obesity, contribute to the mildly reduced eGFR in middle-aged and elderly Chinese.

Authors:  Chuan Wang; Kai Liang; Xiuping Zhang; Chengqiao Li; Weifang Yang; Zeqiang Ma; Yu Sun; Jun Song; Peng Lin; Lei Gong; Meijian Wang; Fuqiang Liu; Wenjuan Li; Juan Xiao; Fei Yan; Junpeng Yang; Lingshu Wang; Meng Tian; Jidong Liu; Ruxing Zhao; Xinguo Hou; Li Chen
Journal:  Int Urol Nephrol       Date:  2014-08-07       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.